- Home
- THTX vs ERNA Comparison
THTX vs ERNA Comparison
Compare THTX & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- ERNA
- Stock Information
- Founded
- THTX 1993
- ERNA 2018
- Country
- THTX Canada
- ERNA United States
- Employees
- THTX N/A
- ERNA N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- THTX Health Care
- ERNA Health Care
- Exchange
- THTX Nasdaq
- ERNA Nasdaq
- Market Cap
- THTX 56.1M
- ERNA 56.4M
- IPO Year
- THTX N/A
- ERNA N/A
- Fundamental
- Price
- THTX $1.18
- ERNA $0.84
- Analyst Decision
- THTX Hold
- ERNA
- Analyst Count
- THTX 1
- ERNA 0
- Target Price
- THTX N/A
- ERNA N/A
- AVG Volume (30 Days)
- THTX 29.7K
- ERNA 89.2K
- Earning Date
- THTX 10-10-2024
- ERNA 11-12-2024
- Dividend Yield
- THTX N/A
- ERNA N/A
- EPS Growth
- THTX N/A
- ERNA N/A
- EPS
- THTX N/A
- ERNA N/A
- Revenue
- THTX $84,316,000.00
- ERNA $598,000.00
- Revenue This Year
- THTX $5.60
- ERNA N/A
- Revenue Next Year
- THTX $4.62
- ERNA N/A
- P/E Ratio
- THTX N/A
- ERNA N/A
- Revenue Growth
- THTX 5.75
- ERNA 1072.55
- 52 Week Low
- THTX $1.08
- ERNA $0.80
- 52 Week High
- THTX $2.58
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- THTX 40.63
- ERNA 32.31
- Support Level
- THTX $1.21
- ERNA $1.05
- Resistance Level
- THTX $1.28
- ERNA $1.20
- Average True Range (ATR)
- THTX 0.07
- ERNA 0.12
- MACD
- THTX -0.01
- ERNA -0.01
- Stochastic Oscillator
- THTX 9.37
- ERNA 7.76
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.